Göran Engberg
Professor
E-postadress: goran.engberg@ki.se
Telefon: +46852486717
Besöksadress: Solnavägen 9, Biomedicum C5, 17165 Solna
Postadress: C3 Fysiologi och farmakologi, C3 FyFa Cmps Elektrofysiologisk Neurofarmakologi, 171 77 Stockholm
Om mig
- Professor i farmakologi vid institutionen för fysiologi och farmakologi.
Göran Engberg är född i Ulricehamn 1952. I Uppsala läste han kurser i medicin 1975-77 och flyttade sedan till Göteborg där han började forska vid den institution som sedermera nobelpristagaren Arvid Carlsson var verksam vid. 1981 disputerade Göran Engberg vid Göteborgs universitet på en avhandling om noradrenalin i hjärnan. 1984 blev han docent i farmakologi och var under åren 1986-1995 anställd som universitetslektor i farmakologi vid Göteborgs universitet.
Göran Engberg flyttade därefter över sin forskning till Karolinska Institutet, institutionen för fysiologi och farmakologi, där han varit universitetslektor i farmakologi sedan 1995. Från 1998 är han studierektor vid KI i samma ämne.
Göran Engberg utnämndes den 1 juni 2002 till professor i farmakologi vid Karolinska Institutet.
Forskningsbeskrivning
- Kynurensyra förekommer normalt i låga koncentrationer i hjärnan. Den antas bland annat ha till uppgift att reglera funktionen av den viktiga signalsubstansen glutamat genom sin förmåga att blockera glutamatreceptorerna i hjärnan. Tidigare har det visats att ämnen med denna egenskap kan framkalla samma symtom som är utmärkande vid schizofreni. En nyligen framlagd hypotes går ut på att kynurensyra som bildas efter aktivering av hjärnans immunsystem spelar en viktig roll för att utveckla sjukdomen.
Artiklar
- Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2024;171:306-315
- Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2024;17:11786469241245323
- Article: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2023;77(12):665-671
- Article: ACTA NEUROPSYCHIATRICA. 2023;:1-13
- Article: SCHIZOPHRENIA RESEARCH. 2023;257:34-40
- Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2023;111:376-385
- Article: NATURE COMMUNICATIONS. 2022;13(1):6427
- Article: MOLECULAR PSYCHIATRY. 2022;27(8):3247-3261
- Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):229
- Article: MOLECULAR PSYCHIATRY. 2021;26(11):6820-6832
- Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2021;14:11786469211041368
- Article: JOURNAL OF NEUROIMMUNOLOGY. 2020;349:577401
- Article: MATERIALS CHARACTERIZATION. 2020;170:110726
- Article: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2020;270(7):933-938
- Article: NATURE COMMUNICATIONS. 2020;11(1):4016
- Article: IBRO REPORTS. 2020;8:136-142
- Article: NATURE NEUROSCIENCE. 2019;22(10):1617-1623
- Article: SCHIZOPHRENIA RESEARCH. 2019;210:221-227
- Article: JAMA PSYCHIATRY. 2019;76(7):739-748
- Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):37
- Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):12
- Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2019;12:1178646919891169
- Article: BIOLOGICAL PSYCHIATRY. 2018;84(9):644-654
- Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(5):432-440
- Article: NEUROPHARMACOLOGY. 2018;138:130-139
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(22):E5154-E5163
- Article: MOLECULAR PSYCHIATRY. 2018;23(5):1244-1250
- Article: JOURNAL OF NEUROIMMUNOLOGY. 2017;313:1-9
- Article: MOLECULAR PSYCHIATRY. 2017;22(6):850-856
- Article: ACTA PSYCHIATRICA SCANDINAVICA. 2017;135(5):439-447
- Article: ACTA NEUROPSYCHIATRICA. 2017;29(1):54-58
- Article: PSYCHIATRY RESEARCH. 2017;247:105-112
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;84(5):262-271
- Article: MOLECULAR PSYCHIATRY. 2016;21(10):1342-1350
- Article: NEUROCHEMICAL RESEARCH. 2016;41(9):2243-2255
- Article: NEUROPHARMACOLOGY. 2016;102:42-47
- Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2016;51:47-55
- Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2015;40(2):126-133
- Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2015;8:49-52
- Article: MOLECULAR PSYCHIATRY. 2014;19(3):334-341
- Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2014;36:80-89
- Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2014;7:15-22
- Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2013;6:89-96
- Article: BIPOLAR DISORDERS. 2012;14(7):719-726
- Article: SCHIZOPHRENIA BULLETIN. 2012;38(3):426-432
- Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2012;37(1):53-57
- Article: JOURNAL OF INFLAMMATION. 2011;8:25
- Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2011;36(2):114-118
- Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2010;35(3):195-199
- Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2009;12(4):501-512
- Article: JOURNAL OF NEUROSCIENCE RESEARCH. 2008;86(16):3674-3683
- Article: LIFE SCIENCES. 2008;83(5-6):170-175
- Article: NEUROPHARMACOLOGY. 2007;53(8):918-924
- Article: PHYSIOLOGY & BEHAVIOR. 2007;92(1-2):203-209
- Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2007;41(1-2):144-151
- Article: SYNAPSE. 2006;59(5):290-298
- Article: SCHIZOPHRENIA RESEARCH. 2005;80(2-3):315-322
- Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2005;8(3):329-339
- Article: JOURNAL OF NEURAL TRANSMISSION. 2005;112(7):863-872
- Article: BMC PSYCHIATRY. 2005;5:6
- Article: SYNAPSE. 2004;52(2):114-122
- Article: LIFE SCIENCES. 2003;72(24):2793-2801
- Article: ACTA PHYSIOLOGICA. 2002;175(1):45-53
- Article: SYNAPSE. 2002;43(4):227-237
- Article: NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY. 2002;365(3):173-180
- Article: NEUROSCIENCE LETTERS. 2001;313(1-2):96-98
- Article: AMINO ACIDS. 2001;20(4):353-362
- Article: NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY. 2001;363(1):21-27
- Article: LIFE SCIENCES. 2000;67(15):1901-1911
- Article: SYNAPSE. 2000;37(2):104-108
- Article: NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY. 2000;362(1):41-45
- Article: JOURNAL OF NEURAL TRANSMISSION. 1999;106(5-6):383-394
- Article: NEUROPSYCHOPHARMACOLOGY. 1999;20(3):287-296
- Article: NEUROSCIENCE LETTERS. 1998;255(2):115-118
- Article: NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY. 1998;357(6):611-619
- Article: SYNAPSE. 1997;25(2):215-226
- Article: JOURNAL OF NEURAL TRANSMISSION. 1996;103(11):1255-1263
- Visa fler
Alla övriga publikationer
- Letter: BRAIN, BEHAVIOR, AND IMMUNITY. 2023;114:163-164
- Corrigendum: MOLECULAR PSYCHIATRY. 2022;27(3):1855
- Other: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2020;23(8):543-544
- Letter: SCHIZOPHRENIA RESEARCH. 2019;208:490-492
- Letter: BIOLOGICAL PSYCHIATRY. 2019;85(7):e35-e39
- Review: FRONTIERS IN PSYCHIATRY. 2019;10:963
- Letter: SCHIZOPHRENIA RESEARCH. 2018;199:438-441
- Letter: SCHIZOPHRENIA RESEARCH. 2018;195:406-408
- Review: NEUROPHARMACOLOGY. 2017;112(Pt B):297-306
- Review: LAKARTIDNINGEN. 2015;112:DH34
- Letter: SCHIZOPHRENIA RESEARCH. 2011;127(1-3):270-272
- Letter: MOLECULAR PSYCHIATRY. 2009;14(12):1069-1071
- Review: CNS DRUGS. 2009;23(2):91-101
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2008;18:S2-S3
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S536-S537
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S422-S423
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S420-S421
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S419-S420
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S219
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S264-S265
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2006;16:S435-S436
- Review: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY. 2005;29(5):767-769
- Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2003;527:155-165
- Published conference paper: SYNAPSE. 2001;40(4):294-301
- Visa fler